Home /
News
Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.
Company announcement
Kindeva Drug Delivery awarded up to $129 million to supply DuoDote® autoinjectors to the Strategic National Stockpile
U.K. Government grant unlocks £33M investment with Kindeva Drug Delivery for greener inhaler future
WOODBURY, Minn. and ST. LOUIS, Mo.; Aug. 3, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that the company has received a grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF), unlocking a £33 million investment with Kindeva toward enhancing […]
Read more Viatris announces launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first FDA-approved generic version of Symbicort® for people with asthma and chronic obstructive pulmonary disease, in partnership with Kindeva
Launch demonstrates companies’ commitment to bringing complex generic medicines to the market to help increase patient access PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca’s Symbicort® with an Abbreviated […]
Read more Kindeva Drug Delivery, Chiesi Group, and H&T Presspart announce strategic partnership for Dose Counter Technology Production
Woodbury, Minn.; July 11, 2023 (Business Wire) – Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused […]
Read more Meridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion
St. Louis, Mo. and St. Paul, Minn.; April 11, 2023 (Business Wire) – Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 […]
Read more
Kindeva Drug Delivery announces the appointment of David Stevens as Global CCO
ST. PAUL, Minn. and ST. LOUIS, Mo.; April 5, 2023 (Business Wire) – Kindeva Drug Delivery (Kindeva), a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced that David Stevens has joined the organization as global chief commercial officer (CCO). Stevens will spearhead the commercial, business development, and research and […]
Read more Nutriband with Kindeva Drug Delivery select Aversa™ Fentanyl abuse deterrent formulation for commercial scale manufacturing process development
ORLANDO, Fla., April 4, 2023 – Nutriband Inc.(“Company”) (NASDAQ:NTRB) (NASDAQ:NTRBW) with Kindeva Drug Delivery (“Kindeva”) have selected the target AVERSA™ formulation to take forward into commercial scale manufacturing process development for the Company’s patented lead product, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system. AVERSA™ Fentanyl contains Nutriband’s proprietary transdermal abuse deterrent technology which can be […]
Read more Kindeva and Meridian combine: Create leading drug-device combination product CDMO
ST. PAUL, Minn. and ST. LOUIS, Mo.; Dec. 12, 2022 (Business Wire)— Kindeva Drug Delivery (“Kindeva”) and Meridian Medical Technologies (“Meridian”) announced today the completion of the transaction to combine the two companies. The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate […]
Read more Kindeva Drug Delivery and Meridian Medical Technologies to combine
St. Paul, MN (November 14, 2022) — Kindeva Drug Delivery (“Kindeva”) announced today that it will combine with Meridian Medical Technologies (“Meridian”). The combination will create a leading global drug-device combination product Contract Development and Manufacturing Organization (“CDMO”). Kindeva and Meridian will continue to operate independently until closing. The combined company will have a substantial […]
Read more Kindeva Drug Delivery announces collaboration with the Temple University School of Pharmacy
October 13, 2022 Woodbury, MN — Kindeva Drug Delivery LP (Kindeva) has announced a collaboration with the Temple University School of Pharmacy to provide liquid intradermal transdermal system units for the evaluation of nanoparticle-based approaches to overcome tumor drug resistance in rodent models. Jayanth Panyam, professor of pharmaceutical sciences and dean of the Temple University […]
Read moreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.